Herein, our results reveal that Ubenimex reverses CDDP resistance in GC cells, partly by suppressing autophagy and EMT development, in which inactivation of the CD13/EMP3/PI3K/AKT/NF-κB pathway is indispensable. The gene discussed is AKT1; the disease is gastric cancer.